Central Texas Clinical Research
900 East 30th Street
Austin, Texas 78705
512-480-9660 http://www.ctcrcorp.com tbrinson@ctcrcorp.com

Use our guide to learn which trials are right for you!

CTCR is a dedicated research site located on a major medical campus anchored by St. David's Hospital - a 400+ bed acute care hospital. We have a full time site manager and 5 highly motivated study coordinators. Also on campus are a geropsychiatric hospital, physical rehabilitation hospital and an LTAC facility. Additionally, there are dozens of private medical practices including those of most of our physicians. Two other large hospitals and a multispecialty residency program are also within 2 miles of our offices. We are only one block from The University of Texas at Austin with it's population of almost 50,000 students. Our facility is privately owned by local physicians who are closely involved with day to day operation of the unit. CTCR was formed in 1999 and has grown rapidly ever since as we strive to provide ever better service to those developing new medications.

Our Mission Statement:
Central Texas Clinical Research was founded by physicians with the goal of providing high quality data in an expeditious manner to facilitate the availability of new therapeutic options for the general public. We believe that by doing so, we can benefit people throughout the world.

We do a lot of work with HIV therapeutics, vaccines, and disease modifying agents including anabolics and erythropoesis stimulating agents. In several of our studies over the last few years in this clinical area, we were the highest enrolling site in the nation.

We similarly do a lot of work with hepatitis C and have access to a very large patient population with this illness.

We have experience working on studies in chronic renal failure patients (both dialysis and non-dialysis patients). We have experience with administering agents during dialysis as needed in the 4 dialysis units available to us.

In the past, we have also performed hyperlipidemia work and currently have several studies for type II diabetic patients using both insulin and oral agents.

We have conducted several successful trials for agents treating peripheral neuropathy and will be starting our first sexual dysfunction study this fall.

Most of the studies we do are phase II-III although we have really enjoyed the few phase I's that we have done and have enrolled those quite well. We have some phase IV experience as well but do not do these as often.

We are hoping to try some additional areas this year including: hypertension, osteoporosis, dementia, depression, insomnia and anxiety.

We are fortunate to have almost 20 specialists who are willing to help our primary physicians in studies involving multiple areas of medicine. Some of our physicians have as much as 15 years experience in clinical research. Several hold or have held faculty appointments.

We can provide lists of all our investigators and their C.V.'s as needed. Represented are cardiology, family practice, gastroenterology, nephrology, neurology, obstetrics/gynecology, orthopedic surgery, podiatry, and psychiatry. We have chosen these physicians based on the quality of their work, their interest in research, and their excellent interpersonal skills. Most of them have extensive research experience.

Within a 3 mile radius are some of the poorest and wealthiest neighborhoods in the city. Asians, Blacks, Caucasians and Hispanics of all ages are well represented. In that radius we also have 2 universities and 2 colleges collectively having a student body of approximately 60,000. We draw on the patients of our investigators for studies as well as advertising on radio, television and in the local papers. We have close relations with most of our local television stations and they have helped us to be the highest enrollers in the country in several of our most challenging studies.


Cardiology/Vascular Diseases
Dermatology/Plastic Surgery
Endocrinology
Gastroenterology
Immunology/Infectious Diseases
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Psychiatry/Psychology

Currently we do mostly outpatient studies though we have completed successfully one in hospital cardiology study and hope to start overnight pharmacokinetic and abuse liability studies in the near future. Onsite, we have minus 70 and minus 20 freezers as well as a temperature monitored medical refrigerator. We also have a Heraeus Labofuge 400 centrifuge. We also have worked with both central and local labs and centralized ECG and nerve conduction interpretations. We have our own device for measuring nerve conduction velocities and an impedance body fat analyzer. We are located less than 20 minutes from Austin's airport and excellent and affordable hotels are less than 5 minutes away-one within walking distance. We are on major bus routes and also on major north-south and east-west thoroughfares for our city. We are less than 2 miles from the city center and sited among ethnically and economically diverse neighborhoods.


Tom Brinson
Site Manager
Central Texas Clinical Research
900 East 30th Street
Suite #302
Austin, TX 78705
USA
512-480-9660
512-480-8244 (fax)
tbrinson@ctcrcorp.com
www.ctcrcorp.com


We've found
5 trials
at this facility
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT
Status: Enrolling
Updated: 4/18/2017
mi
from
Austin, TX
Click here to add this to my saved trials
Influenza A Clinical Trial
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
Status: Enrolling, Phase II
Updated: 7/28/2015
mi
from
Austin, TX
Click here to add this to my saved trials
HIV Clinical Trial
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling, Phase III
Updated: 3/22/2016
mi
from
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials